Details for 2017829372

Up to date per 21.04.2026

Actions

Title / Product Name

ZUSAMMENSETZUNGEN UND VERFAHREN IM ZUSAMMENHANG MIT PYRIDINOYLPIPERIDIN-5-HT1F-AGONISTEN

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2017829372

EP Publication Number

3551617

E-Number

1419272

Language

PCT Number

US17064652

Publication Date

16.10.2019 A

11.08.2021 B1

Registration Date

11.08.2021

AT Publication Date

15.09.2021

Application Date

05.12.2017

Registration Number

Priorities

06.12.2016

201662430662 P

IPC

C07D 401/06 20060101AFI20180615BHEP

Maximum Duration of Protection

05.12.2037

Owner

CoLucid Pharmaceuticals, Inc.c/o Eli Lilly and Company Lilly Corporate Center Indianapolis, IN 46285US

Representative

Schwarz & Partner Patentanwälte GmbHWipplingerstraße 301010 WienAT

Inventor

ALLIERI, Brigidac/o Eli Lilly and Company Lilly Corporate Center Indianapolis, IN 46285US

FAGAN, Paulc/o Eli Lilly and Company Lilly Corporate Center Indianapolis, IN 46285US

SHARP, Emmac/o Johnson Matthey Plc 250 Cambridge Science Park Milton Road Cambridge Cambridgeshire CB4 0WEGB

SKWIERCZYNSKI, Raymond, D.c/o Eli Lilly and Company Lilly Corporate Center Indianapolis, IN 46285US

Information about Fees